iNova Pharmaceuticals (Australia) Pty Ltd v Letos Group Pty Ltd (No 3)

Link copied
Case Copied 18 min read

FEDERAL CIRCUIT AND FAMILY COURT OF AUSTRALIA

(DIVISION 2)

iNova Pharmaceuticals (Australia) Pty Ltd v Letos Group Pty Ltd (No 3) [2023] FedCFamC2G 801

File number(s): SYG 3343 of 2019
Judgment of: JUDGE MANOUSARIDIS
Date of judgment: 1 September 2023
Catchwords: INTELLECTUAL PROPERTY – Practice and procedure – orders for summary judgment and judgment by default had been made and entered subject to further submissions on the assessment of compensation, interest, and costs – orders made for compensation, interest, and costs.
Legislation:

Competition and Consumer Act 2010 (Cth) Sch 2, s 236

Copyright Act 1968 (Cth) s 115(2)

Federal Circuit and Family Court of Australia Act 2021 (Cth) s 212

Trade Marks Act 1995 (Cth) ss 126(1)(b), 126(2)

Federal Circuit and Family Court of Australia (Division 2) (General Federal Law) Rules 2021 (Cth) r 22.02(2)

Cases cited:

A2B Australia Limited v Verma [2021] FedCFamC2G 204

iNova Pharmaceuticals (Australia) Pty Ltd v Letos Group Pty Ltd [2022] FedCFamC2G 1052

Division: General
Number of paragraphs: 20
Date of last submission/s: 5 May 2023
Date of hearing: 1 March 2023
Place: Sydney
Counsel for the Applicants: Ms F St John
Solicitor for the Applicants: Gilbert + Tobin
The Fifteenth, Sixteenth, and Twentieth Respondents: Appeared in person, with the assistance of an interpreter
The Fourth, Fifth, Sixth, Seventh, Eleventh, Twelfth, Thirteenth, and Fourteenth Respondents: No appearance by, or on behalf of, the Fourth, Fifth, Sixth, Seventh, Eleventh, Twelfth, Thirteenth and Fourteenth Respondents

ORDERS

SYG 3343 of 2019

FEDERAL CIRCUIT AND FAMILY COURT OF AUSTRALIA (DIVISION 2)

BETWEEN:

INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD ACN 617 871 539

First Applicant

INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED UEN 200617543H

Second Applicant

AND:

LETOS GROUP PTY LTD ACN 623 106 561

Fourth Respondent

LIYAN LIANG

Fifth Respondent

C&J AUS GROUP PTY LTD ACN 617 599 961 (and others named in the Schedule)

Sixth Respondent

ORDER MADE BY:

JUDGE MANOUSARIDIS

DATE OF ORDER:

1 SEPTEMBER 2023

THE COURT ORDERS THAT:

1.Pursuant to s 236 of Schedule 2 to the Competition and Consumer Act 2010 (Cth), s 126(1)(b) of the Trade Marks Act 1995 (Cth) (Trade Marks Act), and s 115(2) of the Copyright Act 1968 (Cth) (Copyright Act):

(a)the fourth respondent (Letos Group Pty Ltd) and the fifth respondent (Liyan Liang) pay:

(i)$46,798.20 to the first applicant (iNova Australia); and

(ii)$79,380.35 to the second applicant (iNova Singapore);

(b)the sixth respondent (C & J Aus Group Pty Ltd) and the seventh respondent (Taiyi Chang) pay:

(i)$11,971.60 to iNova Australia; and

(ii)$20,323.30 to iNova Singapore; and

(c)eleventh respondent (Jun Wei Pty Ltd), the twelfth respondent (Ningning Wei), and the thirteenth respondent (Li Bin) pay:

(i)$58,305.24 to iNova Australia; and

(ii)$98,888.87 to iNova Singapore.

2.Pursuant to s 126(2) of the Trade Marks Act:

(a)the fourth respondent (Letos Group Pty Ltd) and the fifth respondent (Liyan Liang) pay:

(i)$23,399.10 to the iNova Australia, being 50% of the amount specified in order 1(a)(i); and

(ii)$39,690.17 to the iNova Singapore, being 50% of the amount specified in order…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read iNova Pharmaceuticals (Australia) Pty Ltd v Letos Group Pty... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2023] FedCFamC2G 801
Decision Date

CaseChat Overview and Summary

In the Federal Circuit and Family Court of Australia, iNova Pharmaceuticals (Australia) Pty Ltd and iNova Pharmaceuticals (Singapore) Pte. Ltd. (collectively referred to as the applicants) brought an action against Letos Group Pty Ltd, Liyan Liang, C&J Aus Group Pty Ltd, Taiyi Chang, Jun Wei Pty Ltd, Ningning Wei, Li Bin, FY Health Pty Ltd, Mingfang Xue, and Yuan He (collectively referred to as the respondents). The applicants alleged that the respondents engaged in trademark infringement, copyright infringement, misleading and deceptive conduct, and passing off. The court had already made declarations and granted injunctions in favour of the applicants against the respondents. The court reserved the decision on compensation, interest, and costs until further evidence was presented. At a hearing on 1 March 2023, the applicants presented further evidence and argued their case for compensation, interest, and costs. The fourteenth, sixteenth, and twentieth respondents did not appear or present any evidence or submissions, and the applicants informed the court that they had reached a settlement with those respondents. The court proceeded to assess the applicants' claims for damages, interest, and costs against the remaining respondents.

The court found that the applicants' evidence, particularly the affidavits of Mr. Sachin Roneal Deo, Ms. Sally Louise Davitt, and Ms. Kate Messiter, adequately demonstrated the impact of the respondents' infringing conduct on the applicants' profits. The court accepted the applicants' calculations of damages, interest, and costs, which were based on the report prepared by Ms. Davitt and the affidavit of Mr. Michael John Williams. The court made orders for compensation, additional damages, and interest for the amounts claimed by the applicants against the remaining respondents. The court also made lump sum costs orders against the remaining respondents based on the applicants' submissions and the principles stated in A2B Australia Limited v Verma.

The court's decision in iNova Pharmaceuticals (Australia) Pty Ltd v Letos Group Pty Ltd (No 3) involved the assessment of compensation, interest, and costs in a trademark and copyright infringement case. The court found that the applicants' evidence was sufficient to support their claims for damages, interest, and costs against the remaining respondents. The court accepted the applicants' calculations of these amounts and made orders accordingly. The decision demonstrates the court's consideration of the principles and factors involved in assessing compensation, interest, and costs in intellectual property cases.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established